Magnetar Financial LLC Jazz Pharmaceuticals PLC Transaction History

Magnetar Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $1.92 Million - $2.21 Million	-16,655 Reduced 82.73%	3,476 $418,000
Q4 2023 Feb 13, 2024	BUY	$114.26 - $136.0 $2.3 Million - $2.74 Million	20,131 New	20,131 $2.48 Million
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $3.05 Million - $3.67 Million	24,929 New	24,929 $3.09 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $10.3 Million - $12.6 Million	-86,259 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $3.91 Million - $5.62 Million	30,389 Added 54.39%	86,259 $11.2 Million
Q2 2021 Aug 06, 2021	BUY	$160.2 - $186.42 $7.56 Million - $8.8 Million	47,203 Added 544.63%	55,870 $9.93 Million
Q1 2021 May 14, 2021	BUY	$150.19 - $173.5 $10,212 - $11,798	68 Added 0.79%	8,667 $1.43 Million
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $399,208 - $458,087	3,046 Added 54.85%	8,599 $1.16 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $791,968 - $864,046	5,553	5,553 $812,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.